Clinical trial
Once-A-Month Steroid Treatment for Patients With Focal Segmental…
NCT00004990 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00004990 |
|---|---|
| Title | Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis |
| Official title | Pulse Dexamethasone in Focal Segmental Glomerulosclerosis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Glomerulonephritis, Nephrotic Syndrome |
| Intervention type | Drug |
| Interventions | Dexamethasone |
| Enrollment | 20 |
| Start date | Mar 1, 2000 |
| Completion | Dec 1, 2004 |
| First posted | Mar 20, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: